Expression of VLA-alpha 2, VLA-alpha 6, and VLA-beta 1 chains in normal mucosa and adenomas of the colon, and in colon carcinomas and their liver metastases.
about
Focal Adhesion Kinase-Dependent Role of the Soluble Form of Neurotensin Receptor-3/Sortilin in Colorectal Cancer Cell DissociationHuman enterocyte (Caco-2) migration is modulated in vitro by extracellular matrix composition and epidermal growth factorCell surface molecules and their prognostic values in assessing colorectal carcinomas.Integrins: a role as cell signalling molecules.Impairement of HT29 Cancer Cells Cohesion by the Soluble Form of Neurotensin Receptor-3.Diminished expression of integrin adhesion molecules on human colonic epithelial cells during the benign to malign tumour transformation.Altered glycosylation of integrin adhesion molecules in colorectal cancer cells and decreased adhesion to the extracellular matrix.BCL-2 modifying factor (BMF) is a central regulator of anoikis in human intestinal epithelial cells.Tissue architecture: the ultimate regulator of epithelial function?Integrin expression in esophageal squamous cell carcinoma: loss of the physiological integrin expression pattern correlates with disease progressionP-selectin activates integrin-mediated colon carcinoma cell adhesion to fibronectinCollagen receptor control of epithelial morphogenesis and cell cycle progression.Distribution of integrin cell adhesion molecules in endometrial cancer.Extracellular matrix components induce endocrine differentiation in vitro in NCI-H716 cells.Loss of cell-cell and cell-matrix adhesion molecules in colorectal cancer.Multiplicity of fibronectin-binding alpha V integrin receptors in colorectal cancer.Regulation of keratin and integrin gene expression in cancer and drug resistance.Expression of focal adhesion kinase and alpha5 and beta1 integrins in carcinomas and its clinical significance.Prognostic value of β1 integrin expression in colorectal liver metastasesPredominant role of alpha 4-integrins for distinct steps of lymphoma metastasis.The role of toll-like receptors in colorectal cancer progression: evidence for epithelial to leucocytic transition.α2 Integrin-Dependent Suppression of Pancreatic Adenocarcinoma Cell Invasion Involves Ectodomain Regulation of Kallikrein-Related Peptidase-5.Inhibition of cell attachment, invasion and metastasis of human carcinoma cells by anti-integrin beta 1 subunit antibody.Expression of the VLA beta 1 integrin family in bladder cancer.Distribution of VLA integrins in solid tumors. Emergence of tumor-type-related expression. Patterns in carcinomas and sarcomas.Integrins as differential cell lineage markers of primary liver tumors.Expression of alpha(v)beta6 integrin in oral leukoplakia.Application of a novel method of double APAAP staining with subsequent quantitative image analysis to the examination of integrin expression in undifferentiated-type gastric carcinomas.Altered integrin expression in adenocarcinoma of the breast. Analysis by in situ hybridization.Alterations of integrin expression in human lung cancer.Loss of VLA-2 collagen receptor in breast carcinoma, facilitating invasion and metastasis.
P2860
Q28067118-64D315D0-2734-4B93-9E30-F7EEF4954627Q33229227-6BD85834-57DF-4E49-B574-7299028129EEQ33818072-3B865CF9-336F-4E5A-BA8D-676D08B79501Q33850089-972582AB-4F8B-4961-8D24-A01789740CD1Q34170538-CD5B5AEF-198E-460E-A228-7E021FBA5361Q34375111-D9EA4BCF-D5A9-4B9C-B364-C80F8D10CEDAQ34377053-8AE1F61B-88DE-4E55-9A1F-65BEBF1CE4CAQ35128196-CA68D2AD-8F89-4DCE-A222-7EA19D47B20EQ35212052-A72AE2F9-7E74-4931-81BC-6C01646182D4Q35421768-8CFF9CEA-756A-40B6-821C-6F94E9A20A3AQ35754163-B3707D47-DF0A-4170-B6E1-24B9BFD36172Q35787829-54868E9C-0157-4E61-AA50-25218464DA96Q35794894-539138A3-5EAD-4E7B-A418-FE6CDF7A0E04Q35832531-ADCFDB0C-7964-4FED-9C17-CE7C640B34D7Q35976571-3F2D610C-BF5A-44A3-AB2C-8A8FCEECA39AQ36134324-C2EC2189-5685-4B4B-B64E-34A6AFB5D531Q36254808-CDB3197B-BDA7-45CF-842F-91EB3A577316Q36308168-6895559E-0A97-4909-AE91-BD7089A5F8CCQ37452274-98FF3F4C-6BF5-4025-BE5A-4EA934C68C16Q37605964-69950AA2-2ECC-4236-9509-E79FFAE02907Q38264904-899A6973-69AB-4EAD-B6D0-D1B3B58B1DCBQ39988748-AA4E023F-6782-436A-9FBB-947A79CC12BAQ41593282-1BBF3014-0085-46B7-BB6C-125F46B5BDAFQ41889824-73BFCF0F-C3CE-4EF9-ADAA-5A7244D2121FQ41894191-2A96A8F5-62FD-4598-A9BB-9E3C500996C1Q42125011-18F2FD96-044B-4025-A4AF-5C4060A1D382Q42152135-7DF7B380-9B1D-4835-9FE3-AA7802948545Q42641315-133AA7AF-5223-4777-A55C-81A238FED5F0Q42755037-4E47426D-708D-44D3-8268-31DAB9F69370Q42809654-8E9DA8E4-F721-4AD7-B4B6-8C48EDE4C4E7Q55058076-E30EF9B2-5B7D-447E-918B-2E5FC506F9F6
P2860
Expression of VLA-alpha 2, VLA-alpha 6, and VLA-beta 1 chains in normal mucosa and adenomas of the colon, and in colon carcinomas and their liver metastases.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Expression of VLA-alpha 2, VLA ...... as and their liver metastases.
@ast
Expression of VLA-alpha 2, VLA ...... as and their liver metastases.
@en
type
label
Expression of VLA-alpha 2, VLA ...... as and their liver metastases.
@ast
Expression of VLA-alpha 2, VLA ...... as and their liver metastases.
@en
prefLabel
Expression of VLA-alpha 2, VLA ...... as and their liver metastases.
@ast
Expression of VLA-alpha 2, VLA ...... as and their liver metastases.
@en
P2093
P2860
P1476
Expression of VLA-alpha 2, VLA ...... as and their liver metastases.
@en
P2093
P2860
P304
P407
P577
1991-03-01T00:00:00Z